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Quantitative PCR and Cytology of Bronchoalveolar Lavage Fluid in
Dogs with Bordetella bronchiseptica Infection
A.M. Canonne, F. Billen, C. Tual, E. Ramery, E. Roels, I. Peters, and C. Clercx
Background: The use of quantitative PCR (qPCR) for detection of Bordetella bronchiseptica in bronchoalveolar lavage ﬂuid
(BALF) and demonstration of bacteria adhering to ciliated epithelial cells in BALF or bronchial brushing ﬂuid (BBF) has not
been assessed in a series of aﬀected dogs. Coinfections can worsen the clinical severity in bordetellosis, but the speciﬁc associa-
tion withMycoplasma cynos has not been evaluated.
Objectives: To assess the utility of culture, qPCR and cytologic examination of cytospin preparations in the diagnosis of
bordetellosis in dogs and the inﬂuence of coinfection by M. cynos on disease severity.
Animals: Twenty-four referred dogs with B. bronchiseptica infection and 10 healthy dogs.
Methods: Retrospective case series. qPCR (B. bronchiseptica and M. cynos) and culture results from BALF were recorded.
Cytospin preparations from BALF and BBF were reviewed. qPCR on BALF from 10 healthy dogs were used as negative
control.
Results: The BALF culture and qPCR detected B. bronchiseptica in 14/24 and 18/18 dogs, respectively. Coccobacilli were
found adhering to ciliated epithelial cells in 20 of the 21 BALF cytologic preparations where epithelial cells were found, and
2/3 BBF cytologic preparations. Quantitative PCR detected a low level of B. bronchiseptica in one healthy dog. The fre-
quency of detection of M. cynos was not signiﬁcantly diﬀerent in B. bronchiseptica (9/17 dogs) compared with healthy dogs
(2/10 dogs) (P = .09).
Conclusion and Clinical Importance: Quantitative PCR detection of B. bronchiseptica in BALF appears to be a useful diag-
nostic tool. Cytologic examination of BALF or BBF, when positive, allows a rapid and reliable diagnosis.
Key words: Bronchial brushing ﬂuid; Clinical pathology; Cytology; Mycoplasma cynos; qPCR.
Bordetella bronchiseptica is a small aerobic gram-negative rod with coccobacillary appearance, which
is regarded as one of the primary causative agents of
infectious respiratory disease in dogs (CIRD or « ken-
nel cough »). Despite the widespread availability of
B. bronchiseptica vaccines, the infection is still com-
monly seen in young dogs, especially in boarding ken-
nels. This contagious disease is often self-limiting, but a
wide range of respiratory signs are described, from mild
illness to severe pneumonia and death, depending on
factors such as the presence of concomitant viral or
other bacterial pathogens and immune and vaccination
status.1–3 B. bronchiseptica can exist in the respiratory
tract as either a commensal or pathogen.4,5 Although
the bordetellosis is a relatively common infectious dis-
ease in young dogs, large and recent descriptive clinical
studies of conﬁrmed cases, including referral cases with
prior treatment, are not available.
B. bronchiseptica can be detected using bacterial cul-
ture, and more recently by PCR analysis of various
samples such as pharyngeal swabs,5 bronchoalveolar
lavage ﬂuid (BALF), or transtracheal wash.6 As
B. bronchiseptica has been isolated regularly in clinically
healthy dogs, either by culture from the upper respira-
tory tracts and lungs3,4 or by quantitative PCR (qPCR)
from nasal and pharyngeal swabs,5 it is unclear how a
positive qPCR result from BALF should be interpreted.
Although qPCR has the potential to provide quantita-
tive results based on the cycle threshold (Ct) value, it is
unknown whether Ct values can help diﬀerentiate a
carrier state from a pathological infection.
Furthermore, adherence of B. bronchiseptica to cilia
via adhesion molecules, such as ﬁmbriae and ﬁlamen-
tous hemagglutinin, induction of ciliostasis, and damage
to ciliated epithelium have been implicated in bordetel-
losis pathogenesis.7,8 Accordingly, pleiomorphic cocci or
coccobacilli adhering to cilia of the epithelial cells were
occasionally reported as characteristic cytological fea-
tures in human beings9 and anecdotally reported in
dogs diagnosed with bordetellosis.10 Currently, the diag-
nostic accuracy of cytologic demonstration of
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B. bronchiseptica organisms in cytologic preparations,
such as cytocentrifuged smears of BALF or bronchial
brushing ﬂuid (BBF), has not been reported. Moreover,
although M. cynos was recently identiﬁed as an emerging
and possibly lethal pathogen in CIRD,11–13 the role of
Mycoplasma spp. as primary respiratory pathogens
remains unclear.14–17 In dogs with CIRD, the frequency
of coinfections with Mycoplasma spp., in particular
M. cynos, is unknown.
The aims of this study were: (1) to retrospectively
report the signalment, clinical features, and the frequency
of coinfection by M. cynos in a series of referral, previ-
ously treated dogs or both with B. bronchiseptica infec-
tion and (2) to describe performance of qPCR analysis,
bacterial culture of BALF, and cytologic examination of
BALF, BBF, or both in the diagnosis of B. bronchiseptica
infection in dogs.
Materials and Methods
Case Selection and Data Collection
Client-owned dogs referred to the Liege University Veterinary
Small Animal Teaching Hospital between January 2006 and
September 2014, and diagnosed with B. bronchiseptica infection,
either by positive culture, qPCR, or both of the BALF were retro-
spectively included in the study. Data were collected from the
medical records and included signalment, body weight, clinical
signs, type and date of previous vaccination against B. bronchisep-
tica, hematology, thoracic radiographs results, bronchoscopy and
BALF analysis results, and bronchial brushing results when avail-
able. Bronchoscopy, bronchoalveolar lavage (BAL) procedure, and
BALF laboratory processing were performed as described earlier.18
Brieﬂy, dogs were anesthetized using various anesthetic protocols,
according to anesthetist’s recommendations and a 5-minute pre-
oxygenation period was used. Five to 20 mL aliquots (depending
of the body weight) of sterile saline (NaCl 0.9%) were instilled
twice into a least two diﬀerent lung lobes via a ﬂexible pediatric
endoscope (FUJINON© Paediatric Video-Bronchoscope EB-530S)
under anesthesia, followed by immediate aspiration by gentle suc-
tion. The recovered BALF was immediately processed. Aliquots of
na€ıve BALF were used for quantitative culture (Collard Laborato-
ries, Liege, Belgium), for B. bronchiseptica and M. cynos qPCR
(TDDS Laboratories), for total cell count determination using a
hemocytometer, as well as for cytospin preparation (centrifugation
at 221 g, for 4 minutes at 20°C, Thermo Shandon Cytospin©4).
Diﬀerential cell counts calculations were established by counting a
total of 300 cells at high power ﬁeld on the cytospin preparation.
As in previous study of the authors,19 normal cells counts were
considered to be 400–600/lL; BALF cytology was considered nor-
mal if <12% of neutrophils. The remaining recovered BALF was
centrifuged at 1300 9 g for 15 minutes at 5°C. Supernatant and
cell pellet issued from the centrifugation were stored separately at
80°C. For bronchial brushing, a 1.3-mm sheathed cytology brush
(OLYMPUS © Disposable Cytology Brush BC-203D-2006) was
passed through the biopsy channel of the bronchoscope. The
brush was extended past the end of the bronchoscope and out of
the sheath, rubbed gently back and forth across the mucosal sur-
face of a central airway (a primary or secondary bronchus,
depending on the size of the dog), pulled back into the sheath,
and removed from the bronchoscope. The brush was then
re-extended out of the sheath, briskly agitated in 2 mL of sterile
saline in a sterile cryotube. Cytocentrifuged smears from BBF were
then prepared as for BALF (Thermo Shandon Cytospin©4).
Cytological preparations of BALF and BBF were stained with a
May-Gr€unwald-Giemsa stain and each smear was independently
examined and rereviewed by two authors (Tual C. and Ramery
E.). Samples were not supposed to be contaminated with oropha-
ryngeal material: no sample contained Simonsiella bacteria nor
oropharyngeal squamous cells.
BALF Quantitative Culture
Samples were plated onto several agar plates (Chapman’s, Mac
Conkey’s, CNA and TSS agars) at 35°C for isolation of aerobic
organisms (Collard Laboratories, Liege, Belgium). Standard bio-
chemical methods were used to identify cultured bacteria. The
threshold used to deﬁne clinically relevant bacterial growth was
1.7 9 103 colony-forming units per milliliter of BALF.19 Bacterial
susceptibility testing was performed according to standards of the
Belgian Microbiology Society using disk diﬀusion method.
BALF qPCR for B. bronchiseptica and M. Cynos
Quantitative PCR for B. bronchiseptica and M. cynos testing
were performed by a commercial veterinary diagnostic laboratory.
The qPCR results were expressed as Ct values. After obtaining the
data, Ct values were further categorized into 5 groups, based on the
B. bronchiseptica DNA load, as a helping interpretation guide for
clinicians: very high load (Ct < 20), high load (20.1–24), moderate
load (24.1–28), low load (Ct 28.1–32), and very low load (>32.1).
Control Group and Blank Lavages
To investigate whether a positive qPCR result for B. bronchisep-
tica might possibly either indicate a carrier state or result from con-
tamination during the procedure, qPCR analysis was retrospectively
performed on BALF samples collected from 10 healthy dogs. Bron-
choalveolar lavage ﬂuid samples collected from those healthy dogs
were available from previous studies for which ethical approval had
been previously obtained from the Liege University Local Ethical
Committee. Ten control urban or suburban dogs belonging to vet-
erinary staﬀ or students (8) or from shelters (2), with neither history
nor clinical signs of respiratory problems, were used. Bronchoscopy,
BAL procedure, and BALF laboratory processing had been per-
formed as for B. bronchiseptica dogs, and cytologic examination of
cytocentrifuged preparations of BALF was within normal limits in
each dog. For the retrospective qPCR analysis, the frozen pelleted
cells were thawed and resuspended in a 0.5 mL volume of sterile
0.9% NaCl at the time of qPCR testing.
To further evaluate the risk of samples contamination during
the endoscopic procedure and subsequent false positive results, 15
blank lavages of the channel of the bronchoscope were performed
randomly over the study period after standardized cleaning and
disinfection by a trained technician. Brieﬂy, once the endoscope
was disinfected, 5 mL of sterile saline was ﬂushed into the endo-
scopic channel used for BALF collection and recovered in a sterile
cryotube for qPCR assessment. Two blank samples were obtained
after endoscopic cleaning subsequently to BALF collection in dogs
ﬁnally diagnosed with B. bronchiseptica infection.
Statistical Analysis
Statistical analyses were performed with a commercially avail-
able software (XLstat software). Data were expressed as median
and range for continuous variables and as proportion for categori-
cal variables.
Chi-square test (for n > 5) and exact Fisher’s test (for n ≤ 5)
were used to compare the frequency of qPCR detection of
M. cynos between healthy and B. bronchiseptica dogs.
Values of P ≤ .05 were considered signiﬁcant.
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Results
Signalment and Clinical Findings
Clinical records from 24 dogs diagnosed with
B. bronchiseptica infection between 2006 and 2014 were
retrospectively reviewed. Median age was 0.5 years
(range 0.2–3.8) and median weight was 4.8 kg (range
1.3–30). french bulldogs, cavalier king charles spaniels,
and yorkshire terriers accounted for 15/24 cases. Vacci-
nation status was recorded for 22 dogs. Seven of them
had been vaccinated against B. bronchiseptica infection:
2 had received intranasal vaccine (IN) [Nobivac BbPi©,
Intervet International] (No 4, 10) and 5 subcutaneous
(SC) vaccine [Pneumodog©, Merial Sanoﬁ] (No 3, 5,
15, 17, 19). Five dogs were vaccinated within 3–6 weeks
before onset of clinical sign (No 4, 5, 15, 17, 19) and in
the last 2 dogs, a mild cough was already reported at
the time of vaccination (No 3, 10).
Chronic productive harsh and hacking daily cough of
at least 1 week to 2 year’s duration (median = 2 months)
was present in all cases. In all but 2 dogs, cough was
reported since acquisition. Laryngo-tracheal reﬂex (tra-
cheal sensitivity) was positive in all but three dogs. Thir-
teen dogs were moderately to severely dyspneic; in 7 of
these 13 dogs, hospitalization and oxygen supplementa-
tion were required. A variable degree of lethargy and
mild fever (39.1° to 39.6°C) were observed in 12 and 4
cases, respectively. A mild serous or sero-mucous nasal
discharge was reported in 4 dogs. Twenty dogs had been
unsuccessfully treated with oral antibiotics including
amoxicillin or amoxicillin/clavulanic acid (n = 17), doxy-
cycline (n = 6), marboﬂoxacin or enroﬂoxacin (n = 6),
cephalexin (n = 2) and lincomycin (n = 2). Among these
dogs, at the time of diagnosis, antibiotics had been
stopped for less than 48 hours in 6 dogs and at least
1 week before BALF collection in the 14 remaining
dogs.
Mild to moderate neutrophilic leukocytosis was present
in 14 dogs (for dogs with leukocytosis, median
value = 23.4 9 103/lL, range 15.9–45.5]). A mild
leukopenia was observed in 1 dog (No 7, 5.8 9 103/lL).
Radiographic features included generalized or caudo-
dorsal bronchial or bronchointerstitial pattern (n = 14),
peri-bronchial pattern (n = 4), and alveolar changes
(n = 11). In almost all dogs with alveolar pattern,
lesions were considered severe and predominantly pre-
sented as multifocal patches, often more pronounced in
ventro-cranial lung areas. Bronchoscopy revealed hyper-
emic and edematous mucosa, thickened bronchi or thick
and white-yellow or hemorrhagic material, in moderate
to large amounts, within the bronchial and sometimes
the tracheal lumens in all dogs (Fig 1).
Total cell count of BALF varied from 500 to
39,000 cells/lL (median = 2030 cells/lL) with predomi-
nantly neutrophilic inﬂammation in all but 1 case (dog
No 3, cytology showing predominance of macrophages).
For 22 dogs, the accurate percentage of BALF neu-
trophils was available (median 89%, range 11–98%).
Neutrophils appeared highly segmented with frequent
degenerative changes and sometimes a pyknotic aspect
of the nucleus. Ciliated epithelial cells were present in
cytologic preparations from 21 BALF samples.
B. bronchiseptica Diagnostic Test Results
Bronchoalveolar lavage ﬂuid bacterial culture was
positive for B. bronchiseptica in 14/24 dogs (58%).
Available antibiotic susceptibility was available in 13 of
them, and revealed that all strains were susceptible to
gentamicin and ﬂuoroquinolones; 10/13 and 9/13 strains
were susceptible to doxycycline and amoxicillin/clavu-
lanic acid, respectively. Only 2/13 strains showed sus-
ceptibility to cephalexin and 3rd generation
cephalosporins. Among the 13 dogs for which antibiotic
susceptibility was available, 11 dogs were unsuccessfully
treated with antibiotic drugs prior BALF collection; 9
of these 11 dogs received 1 (1 dog) or 2 (8 dogs) appro-
priate drugs, based on the susceptibility patterns of the
isolated organisms.
Pleiomorphic cocci or coccobacilli were found adher-
ing to the cilia of the epithelial cells in 18/24 cytocen-
trifuged BALF preparations (75%) and in two
cytocentrifuged BBF preparations (Fig 2). In three of
the four dogs for which cytological examination of
BALF was negative (No 2, 6, 13), no ciliated epithelial
cells were found on the cytospin preparation; BBF was
not performed and bacterial culture was also negative.
In the fourth dog (No 14), bacterial culture yielded
B. bronchiseptica growth and identiﬁcation but both
cytological examination of BALF and BBF failed to
detect coccobacilli even though ciliated epithelial cells
were observed on the cytological preparations.
The qPCR was positive for B. bronchiseptica in 18/18
dogs tested; a qPCR Ct-value data for B. bronchiseptica
was available in all but one of them.
In dogs with high and very high B. bronchiseptica
DNA loads (ie, with Ct values lower than 24)
Fig 1. Bronchoscopic view of tracheobronchic bifurcation show-
ing congested mucosa and thick and white-yellow material (Dog
n°3, sharpei, female, 6 months old).
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(n = 9), cytologic examination of BALF was always
positive, whereas culture was positive in 6 of them.
In dogs with moderate B. bronchiseptica DNA load
(ie, Ct values between 24.1 and 28) (n = 7), cytology
of BALF or BBF and culture were positive in three
and two cases, respectively. One BALF showed a low
B. bronchiseptica DNA load (ie, Ct value higher than
28.1) and cytology of BALF from this dog was
positive. Dogs with positive cytology had higher
B. bronchiseptica DNA load (mean Ct = 21.2) com-
pared with dogs with negative cytology (mean
Ct = 26.1) (P = .009).
Among 17 dogs in which qPCR data for M. cynos
were available, 9 dogs (53%) were positive.
Other common bacteria were also cultured in 8/24
(33%).
Control Group and Blank Lavages
The control group was composed of 10 dogs (6
females, 4 males) of various breeds aged from 2 to
11 years (median = 6 years). Bronchoalveolar lavage
ﬂuid culture and cytologic examination of cytocen-
trifuged smears were negative for B. bronchiseptica in
all control dogs. In one of them, qPCR detected a very
low B. bronchiseptica DNA load (Ct = 33.44).
M. cynos was detected by qPCR assay in 2 of the con-
trol dogs. The frequency of detection of M. cynos was
not signiﬁcantly diﬀerent in B. bronchiseptica (9/17 dogs)
compared with healthy dogs (2/10 dogs) (P = .09).
Among the 15 blank lavages, B. bronchiseptica qPCR
was positive at very low grade (Ct = 35.6) in only one
case. This blank lavage was performed after cleaning of
the endoscope subsequently to bronchoscopical examina-
tion in a dog ultimately diagnosed with B. bronchiseptica.
Discussion
This study suggests that, in this speciﬁc population of
aﬀected dogs, referred with mostly chronic clinical
signs, a qPCR detection of B. bronchiseptica in BALF
is a useful diagnostic test. Indeed, qPCR was positive,
with indication of moderate to very high DNA content,
in all suspected animals tested, even when bacterial cul-
ture or cytologic detection were negative. This study
also shows that cytologic examination of BALF and
BBF cytospin preparations allows rapid and reliable
suspicion of B. bronchiseptica infection in the great
majority of dogs; this method seems to be more
sensitive than BALF culture.
The present case series conﬁrms that B. bronchiseptica
infection mainly aﬀects young dogs from small breeds
and that clinical presentation can be quite severe.
Almost all dogs from the present case series were pre-
sented with chronic cough (median = 2 months), while
CIRD is classically associated with a shorter duration
of respiratory signs (less than 2 weeks).3 Of interest,
cavalier king charles spaniels, yorkshire terriers, and
french bulldogs represented more than a half of the
study population. Since the majority of the dogs
aﬀected in this case series were very young, and since
three young french bulldogs developed concomitant
generalized demodicosis, an inadequate or impaired
immune response can be strongly suspected but was not
investigated. In cavalier king charles spaniels, previous
descriptions of Pneumocystosis jiroveci infection, some
of them with concomitant demodicosis, have suggested
that immune incompetence underlies the susceptibility
of this breed to infectious diseases.20
Pleiomorphic cocci or coccobacilli were found adher-
ing to the ciliary apexes and interciliary spaces of the
epithelial cells in 20/24 cytocentrifuged BALF, BBF, or
both, preparations. In comparison, only 14/24 dogs had
positive culture and only 1 dog had negative cytology
despite a positive culture. The pathogenesis of bordetel-
losis involves adherence of the B. bronchiseptica to the
cilia of the respiratory tract.7 In a previous experimental
study using tracheal cell culture models in dogs, elec-
tron microscopy allowed observation of bacteria adher-
ing to cilia of tracheal epithelial cells, although optic
microscopy was not investigated.8 Until the present
study, demonstration of bacteria adhering to ciliated
epithelial cells obtained by BAL or per-endoscopic
bronchial brushing from dogs with spontaneous
B. bronchiseptica infection has not been assessed in the
diagnosis of bordetellosis in dogs. Adhered bacteria
were observed by standard cytology in all dogs with
high and very high B. bronchiseptica DNA loads. These
results suggest that standard cytologic examination of
cytocentrifuged preparations of BALF and BBF allows
reliable suspicion of B. bronchiseptica in the vast major-
ity of dogs. Besides, cytologic preparations can be
immediately assessed, before results of bacterial culture
or qPCR analysis are obtained. Although in some cases,
B. bronchiseptica can be formally identiﬁed, based on
cytological ﬁndings alone, its strict identiﬁcation might
be dependent on the quality of the cytologic prepara-
tions as well as on the expertise of the cytologist. In
theory, any coccobacillus (such as Pasteurella sp. or
Acinetobacter sp.) superimposed on the apical side of
ciliated cells would be falsely diagnosed as
Fig 2. Cytological detection of pleiomorphic cocci or coccobacilli
adhering to the cilia of the epithelial cells of BALF (May-
Gr€unwald-Giemsa stain, 9400 magniﬁcation, Dog n°8, Yorkshire
Terrier, female, 5 months old).
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B. bronchiseptica. In such cases, conﬁrmation is strongly
advised, and in this respect, qPCR on BALF appears
particularly useful. Furthermore, eﬀects of delay of
BALF processing or speed and time of cytocentrifuga-
tion on the number of intact ciliated epithelial cells were
not anticipated in this study; any factor aﬀecting the
integrity of ciliated epithelial cells would reasonably
decrease the relative sensibility of the BALF cytology in
the diagnosis of B. bronchiseptica infection.
In a recent study, BBF was shown to be inferior to
BALF for the diagnosis of septic inﬂammation in
dogs.21 However, among the 6 dogs with negative
BALF cytology, BBF cytology was positive in 2 of the
3 dogs in which this procedure was performed. This
suggests that BBF could be the sample of choice for
cytologic investigation of B. bronchiseptica. This is logi-
cal since higher numbers of ciliated tracheobronchial
cells are recovered by brushing procedures, compared
to BALF, which only contains a low percentage of cili-
ated epithelial cells (<1%).22–24
In this study, bacterial culture was negative in 10/24
dogs while qPCR conﬁrmed the presence of B. bron-
chiseptica in 18/18 tested dogs. This is not surprising
since sensitivity of bacterial culture for the diagnosis of
Bordetella spp. infection (B. bronchiseptica, B. pertussis,
and parapertussis) has been reported to be lower than
PCR in a human study.25 Currently available qPCR
methods are able to detect as few as 10 genome copies
of B. bronchiseptica/lL.26 However, the great majority
of infected dogs had received various antibiotic drugs
before diagnosis and a non-negligible proportion of
them had received antimicrobial treatment within the
48 hours before the bronchoalveolar lavage, which is
susceptible to aﬀect culture results. Because infection
and aerosol shedding can persist for weeks,3 positive
results of both culture and PCR must be interpreted
cautiously. In a recent study, B. bronchiseptica was
detected in up to 45% of healthy dogs using qPCR
analysis on nasal and pharyngeal swabs5, but bronchial
samples were not assessed. Comparative assessment of
qPCR results in aﬀected dogs, healthy dogs, and blank
lavages of the endoscope led us to consider the Ct val-
ues, as well as their interpretation into B. bronchiseptica
DNA loads, as a useful and accurate tool to distinguish
true infection from carrier state or environmental con-
tamination. Indeed, moderate to very high loads were
found in all but 1 aﬀected dog while the load was very
low in both the single blank and the single control sam-
ple, which were positive. We feel conﬁdent that the case
with low B. bronchiseptica DNA load (high Ct value)
(No 16) did suﬀer from bordetellosis since cytology was
positive.
Despite appropriate cleaning and disinfection of the
endoscopic material, a very low B. bronchiseptica DNA
load positive qPCR was obtained in 1 blank lavage
sample; this observation highlights the possibility of
false positive results because of contamination during
the BALF procedure from previously sampled cases.
The question of appropriate disinfection should thus
clearly be considered before interpretation of qPCR
results of BALF. Therefore, it is unclear how the
positive qPCR result from the healthy dog in this study
should be interpreted. Whether it potentially indicates a
carrier state or simply results from a contamination is
unknown.
According to the results of this study, positive culture
or positive cytology or moderate to very high B. bron-
chiseptica DNA loads can be proposed as criteria to
establish a deﬁnitive diagnosis of bordetellosis in dogs
with compatible clinical signs. However, such ﬁndings
do not rule out the possibility of concurrent infections
contributing to clinical presentation. Moreover, this
study included a challenging population of dogs being
referred, frequently with prior unsuccessful treatment
that can have interfered with culture or cytology more
than PCR; in such dogs, qPCR on BALF could be
assumed to be more sensitive than culture or cytology.
However, BALF analysis should always include semi-
quantitative bacterial culture in case of clinical suspi-
cion of B. bronchiseptica infection, in order to identify
common bacterial coinfections and to obtain antimicro-
bial susceptibility patterns.
This study had some limitations. The study group is
comprised of dogs that were referred, and do not repre-
sent the majority of dogs with canine infectious respira-
tory disease complex. Nearly all had received prior
antibiotic treatment and the duration of signs was not
typical (chronic cough), so these dogs might not reﬂect
typical cases. The second major issue concerns the lack
of well-recognized gold standard for the diagnostic of
clinical bordetellosis. Besides, because of retrospective
nature of the study, prior antibiotic treatment in some
dogs may have aﬀected the proportion of dogs with pos-
itive quantitative culture for B. bronchiseptica or other
concomitant bacteria, proportion of dogs with positive
qPCR for M. cynos, and results from all complementary
examinations were not available for all included dogs.
Among B. bronchiseptica dogs, BBF was performed in
only a limited number of them, preventing an adequate
comparison and deﬁnitive conclusion concerning the rel-
ative beneﬁt of the BBF procedure, compared to the
BALF one, for cytologic detection of B. bronchiseptica.
A prospective study including larger groups of infected
and healthy dogs in which BALF, BBF, culture, and
qPCR are performed is warranted. Such a study would
allow the assessment of the sensitivity and the speciﬁcity
of each diagnostic test, assuming that qPCR detection
of B. bronchiseptica at moderate to very high DNA load
in the BALF of a dog with compatible clinical signs
might be considered as a gold standard for the deﬁnitive
diagnosis of canine bordetellosis.
Conclusion
This retrospective clinical case series highlights that
B. bronchiseptica infection can have chronic and some-
times severe and fatal clinical presentations and it com-
monly aﬀects very young dogs of small breeds.
Standard cytologic examination of cytocentrifuged
preparations of BALF, BBF, or both can be considered
as a rapid and inexpensive diagnostic modality. Provid-
ing that the sample is adequately collected and
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processed, qPCR detection of B. bronchiseptica on
BALF, with consideration of the B. bronchiseptica
DNA load, appears to be the most sensitive method for
B. bronchiseptica conﬁrmation in the studied population
since qPCR detection of B. bronchiseptica on BALF
was positive in all cases tested, including those with
negative cytology and bacteriology results.
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